Register for email alerts and news feeds:
This journal | BMJ Group
rss
British Heart Journal 1985;54:539-542; doi:10.1136/hrt.54.5.539
Copyright © 1985 BMJ Publishing Group Ltd & British Cardiovascular Society

Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism--an association.

C Symons, F Fortune, R A Greenbaum, P Dandona

Left ventricular hypertrophy (symmetric, asymmetric, or hypertrophic cardiomyopathy) is an almost invariable accompaniment of primary hyperparathyroidism. Five of 18 patients with hypertrophic cardiomyopathy had raised serum concentrations of parathyroid hormone with normal serum calcium concentrations. Left ventricular hypertrophy did not occur in any of the six patients with hypercalcaemia alone. These relations suggest that parathyroid hormone rather than a rise in the extracellular calcium concentration is associated with a spectrum of left ventricular hypertrophy. All patients with increased circulating parathyroid hormone concentrations should have echocardiographic examination of the left ventricle. Conversely, parathyroid hormone concentrations should be measured in all patients with left ventricular hypertrophy from an unknown cause, especially those with hypertrophic cardiomyopathy.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Wallis, D. E., Penckofer, S., Sizemore, G. W. (2008). The "Sunshine Deficit" and Cardiovascular Disease. Circulation 118: 1476-1485 [Full Text]  
  • Meyer, R., Schreckenberg, R., Kretschmer, F., Bittig, A., Conzelmann, C., Grohe, C., Schluter, K.-D. (2007). Parathyroid hormone-related protein (PTHrP) signal cascade modulates myocardial dysfunction in the pressure overloaded heart. Eur J Heart Fail 9: 1156-1162 [Abstract] [Full Text]  
  • Wallis, D. E., Penckofer, S. (2007). Letter by Wallis and Penckofer Regarding Article, "Calcium/Vitamin D Supplementation and Cardiovascular Events". Circulation 116: e86-e86 [Full Text]  
  • Andersson, P., Rydberg, E., Willenheimer, R. (2004). Primary hyperparathyroidism and heart disease -- a review. Eur Heart J 25: 1776-1787 [Abstract] [Full Text]  
  • Neunteufl, T., Katzenschlager, R., Abela, C., Karam Kostner, , Niederle, B., Weidinger, F., Stefenelli, T. (1998). Impairment of endothelium-independent vasodilation in patients with hypercalcemia. Cardiovasc Res 40: 396-401 [Abstract] [Full Text]  
  • Stefenelli, T., Abela, C., Frank, H., Koller-Strametz, J., Globits, S., Bergler-Klein, J., Niederle, B. (1997). Cardiac Abnormalities in Patients with Primary Hyperparathyroidism: Implications for Follow-Up. J. Clin. Endocrinol. Metab. 82: 106-112 [Abstract] [Full Text]  
  • Parfrey, P. S., Harnett, J. D., Griffiths, S. M., Gault, M. H., Barre, P. E. (1988). Congestive Heart Failure in Dialysis Patients. Arch Intern Med 148: 1519-1525 [Abstract]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.